FDA has announced that Evusheld is not currently authorized for use because it is unlikely to offer protection against the COVID-19 variants that are common today. Evusheld has been an option for people who are moderately or severely immunocompromised and people with a history of severe adverse reaction to a COVID-19 vaccine or its components.
Read More ›CDC has launched the COVID-19 Testing Locator website, which allows consumers to search for free COVID-19 testing sites near them.
Read More ›Because immunity decreases over time, it is till important to get vaccinated even if you were infected with COVID. This post provides guidance on planning for a COVID-19 vaccine if you have COVID or recently have had COVID.
Read More ›Residential households in the U.S. can now order one set of 4 free at-home tests from USPS.com now.
Read More ›Make a COVID-19 plan now so you’re prepared. Consider the ways you will protect yourself and how to be prepared if you get sick with COVID-19. Include how you will adjust your plan if the COVID-19 situation changes in your community.
Read More ›The U.S. Food and Drug Administration announced November 30, 2022 that it is pulling emergency use authorization for the monoclonal antibody treatment bebtelovimab.
Read More ›